Efficacy trial of ingestion of plant derived ingredient. [g2020004(KO22)]
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000041485
- Lead Sponsor
- Kao Corporation
- Brief Summary
A significant difference was observed in the primary outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 16
Not provided
(1) Diabetes mellitus (2) Taking medicine related diabetes mellitus (3) BMI>=30kg/m2 (4) Blood triglyceride>=150mg/dL (5) Taking antihypertensive (6) Having history or presence of cardiovascular disease or cerebrovascular disease (7) Presence of liver, kidney or respiratory disease, endocrine disorder, metabolic disorder, organ disorder, gout, rheumatism, autoimmune disease, allergy disease, mental disorder, cancer, infection disease, or other diseases (8) Having history of resection of gastrointestinal tract (9) Thyroid deficiency (10) Heavy alcohol drinker (over 30g per day) (11) Donated over 200 mL of blood within the last one month prior to the study or over 400 mL of blood within the last three months prior to the study or severe anemia (12) Having felt sick during blood collection (13) Food allergies for test foods or lactose intolerance (14) Tape allergy (15) Caffeine hypersensitivity (16) Planned to participate in other clinical study during current study (17) Shift worker (18) Planned to be examined by X-ray, CT, or MRI (19) Using an implantable medical device such as a pacemaker (20) Undergoing artificial dialysis (21) Within the last 2 weeks, having flu symptoms such as fever, cough, or sore throat, high fever, dyspnea, strong malaise, taste disorders, or olfactory disorders (22) Within the last 2 weeks, having family members or friends infected with COVID-19 or having close contact with infected person (23) Having overseas travel history within 1 month (24) Determined to be unqualified by the physician in charge or the responsible person of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Concentration of blood glucose
- Secondary Outcome Measures
Name Time Method Concentration of blood insulin, GLP-1, and GIP